TrialPlatelets2019

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome.

William A E Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.